Skip to content
Companies

Precision Medical Ventures

AI software that assesses lung nodules on CT scans

Raised to date

$500K

of $2M offered across 1 Form D filing

Still open
$1.5M
Investors
2
Last filed
Mar 24, 2025

About

Precision Medical Ventures Inc. (PMV) is an innovative investment group dedicated to advancing medical technology, particularly within the realms of radiology and healthcare. The company is committed to enhancing patient care and outcomes by developing cutting-edge medical devices and software solutions that address critical challenges in healthcare delivery.

PMV stands out for introducing RevealAI-Lung, the world's first regulatory-cleared CADx software for lung nodule characterization, which significantly enhances diagnostic accuracy and reduces healthcare costs.

Funding

  • Security to be acquiredFiled Mar 24, 2025Form D
    $500K/ $2M

Product

RevealAI-Lung

Diagnostic Software

RevealAI-Lung is a revolutionary computer-aided diagnosis (CADx) software designed specifically for the characterization of lung nodules. It employs advanced algorithms to analyze lung CT scans with high precision, addressing the critical need for accurate assessment and management of lung nodules that could indicate cancer.

  • World's first CADx software for lung nodule characterization to receive regulatory clearance
  • Improves diagnostic precision for better treatment outcomes
  • Significantly reduces healthcare costs associated with lung nodule management

Built for

Hospitals, healthcare facilities, and radiology departments

People on file